Montag & Associates’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Montag & Associates’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-37,964	Closed	-$1.59M	–	291
2018 Q1	$1.59M	Buy	+37,964	New	+$1.65M	0.16%	137

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $23.2M AUM 88.58% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Montag & Associates's XPH Position: Q2 2018 in Review

Montag & Associates sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2018, closing a stake of 37,964 shares — an estimated $1.59M sold.

Montag & Associates first reported a position in XPH in Q1 2018 and held it in 1 quarter. The position peaked at $1.59M in Q1 2018. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

Montag & Associates reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Montag & Associates sold 37,964 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2018, an estimated $1.59M.
Montag & Associates first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2018 and held it in 1 quarter.
Montag & Associates's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.59M in Q1 2018.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on Montag & Associates's 13F filing for Q2 2018, filed 1 Aug 2018.